Osadnik, Tadeusz
Nowak, Dariusz
Osadnik, Kamila
Gierlotka, Marek
Windak, Adam
Tomasik, Tomasz
Mastej, Mirosław
Łabuz-Roszak, Beata
Jóźwiak, Kacper
Lip, Gregory Y. H.
Mikhailidis, Dimitri P.
Toth, Peter P.
Sattar, Naveed
Goławski, Marcin
Jóźwiak, Jacek
Banach, Maciej
,
Funding for this research was provided by:
Valeant
Article History
Received: 13 September 2023
Accepted: 8 November 2023
First Online: 28 November 2023
Declarations
:
: Research involving human subjects complied with all relevant national regulations and institutional policies, was in accordance with the Helsinki Declaration (as revised in 2013), and was approved by the Bioethical Committee of the Chamber of Physicians (No.K.B.Cz.-0018/ 2015).
: Not applicable.
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: J.J. and M.B. have received an unrestricted educational grant from Valeant and have served as consultants or speakers for Valeant. P.T. owns four shares in AstraZeneca PLC and has received honoraria and/or travel reimbursement for events sponsored by AKCEA, Amgen, AMRYT, Link Medical, Mylan, Napp, and Sanofi. All other authors declare no conflicts of interest concerning the results of this analysis. All authors revised the article critically for important intellectual content. All authors gave final approval of the work, have participated sufficiently in the work, and take public responsibility for appropriate portions of the content.